The King of the Monsters is stomping into comic book shops. IDW’s “Godzilla” #1, written by Tim Seeley with art by Nikola Čižmešija, hits shelves soon. And we’ve got the reveal of an exclusive ...

Kesha changed the cover art for her single 'Delusional' after fan backlash over its original AI-generated image, opting for a ...

Kuro Games announced the events and banners for Wuthering Waves version 2.3 Phase 2 (Image via Kuro Games) Kuro Games announced all the events and banners coming with Wuthering Waves 2.3 second phase.

The song I’m proudest of on Virgin.” The cover art is a tight shot of the Grammy winner’s torso with duct tape covering her chest, and fans picked up that it looked almost identical to the ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage cocktail to improved outcomes in patients with bacteria in their blood ...

After facing backlash over the use of AI in the original cover art for her single "DELUSIONAL," released back in November, Kesha is now addressing the controversy by unveiling new artwork for the ...

Nate Wiggins Discusses His Year 2 Goals, Best Matchup From His First Season, And How He's Becoming a Better Pro Ravens CB Nate Wiggins joins team insiders Ryan Mink and Garrett Downing to talk ...

The recent Wuthering Waves 2.6 leaks of character concept art have surprised the community. Coming from credible sources like Step Leaker, the rendered images of Augusta and Younuo aren't the only ...

Open World Games Hideo Kojima says Death Stranding 2's Collector's Edition 15-inch Magellan Man is part of his studio's "spirit and soul," so the crew went to China to make sure it's good enough ...

Finger Eleven guitarist James Black has picked up a new instrument, one that pushes the boundaries of his visual imagination ...

When Do Horrific Visions Start in Patch 11.1.5? Horrific Visions will return starting on May 20th after the weekly reset. This system returns in a form similar to their initial appearance in ...

In an update on its respiratory pipeline this morning, Sanofi said that anti-OX40L antibody amlitelimab failed to meet its primary endpoint in the phase 2 TIDE-Asthma study, involving patients ...